Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Operating Margin (2020 - 2025)

Historic Operating Margin for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 89.84%.

  • Biofrontera's Operating Margin fell 348000.0% to 89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.4%, marking a year-over-year increase of 73600.0%. This contributed to the annual value of 46.11% for FY2024, which is 204400.0% up from last year.
  • Per Biofrontera's latest filing, its Operating Margin stood at 89.84% for Q3 2025, which was down 348000.0% from 56.25% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Operating Margin peaked at 13.63% during Q4 2024, and registered a low of 371.6% during Q3 2021.
  • Its 5-year average for Operating Margin is 81.13%, with a median of 62.89% in 2023.
  • Per our database at Business Quant, Biofrontera's Operating Margin tumbled by -2995200bps in 2021 and then surged by 2874000bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's Operating Margin stood at 20.51% in 2021, then crashed by -168bps to 55.02% in 2022, then skyrocketed by 34bps to 36.48% in 2023, then surged by 63bps to 13.63% in 2024, then crashed by -559bps to 89.84% in 2025.
  • Its Operating Margin stands at 89.84% for Q3 2025, versus 56.25% for Q2 2025 and 52.95% for Q1 2025.